Search

Your search keyword '"Lamb, C"' showing total 1,579 results

Search Constraints

Start Over You searched for: Author "Lamb, C" Remove constraint Author: "Lamb, C"
1,579 results on '"Lamb, C"'

Search Results

1. The UK Divide: Does Having a Pembrolizumab–Chemotherapy Option in Head and Neck Cancer Matter? Real-world Experience of First-line Palliative Pembrolizumab Monotherapy and Pembrolizumab–Chemotherapy Combination in Scotland

3. Intraspecific encounters can lead to reduced range overlap

5. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis.

6. Balancing Prescription with Teacher and Pupil Agency: Spaces for Manoeuvre within a Pedagogical Model for Working with Adolescent Girls

11. Intraspecific encounters can induce home-range shifts

12. Intraspecific encounters can induce home-range shifts

13. Behavioral responses of terrestrial mammals to COVID-19 lockdowns

14. Perception of brassinosteroids by the extracellular domain of the receptor kinase BRI1.

17. Neutralising antibody potency against SARS-CoV-2 wild-type and Omicron BA.1 and BA.4/5 variants in infliximab and vedolizumab treated patients with inflammatory bowel disease after three doses of COVID-19 vaccine: a prospective multicentre cohort study (CLARITY)

18. Development of a core descriptor set for Crohn's anal fistula

19. Author Correction: Somatic mosaicism and common genetic variation contribute to the risk of very-early-onset inflammatory bowel disease (Nature Communications, (2020), 11, 1, (995), 10.1038/s41467-019-14275-y)

25. OP22 Antibody decay, T cell immunity and breakthrough infections following SARS-CoV-2 vaccination in infliximab- and vedolizumab-treated patients

26. P361 PREPARE-IBD: Physician Responses to disease Flares and Patient Adaptation in Relation to Events in Inflammatory Bowel Disease during the COVID-19 pandemic: A multicentre cohort analysis

27. OP01 Withdrawal of infliximab or anti-metabolite therapy in Crohn’s Disease patients in sustained remission on combination therapy: A randomized unblinded controlled trial (SPARE)

31. Relapse after withdrawal from anti-TNF therapy for inflammatory bowel disease: an observational study, plus systematic review and meta-analysis

34. Overview of the JET preparation for deuterium-tritium operation with the ITER like-wall

43. Thiopurine withdrawal during sustained clinical remission in inflammatory bowel disease: relapse and recapture rates, with predictive factors in 237 patients

45. From Field and Study

48. SOCIAL DIFFERENTIATION AMONG RURAL MAYA HOUSEHOLDS IN CHUNHUAYUM, YUCATAN, MEXICO, DURING THE LATE PRECLASSIC THROUGH THE EARLY CLASSIC (300 B.C. ��� A.D. 600)

49. Afterword

Catalog

Books, media, physical & digital resources